Indefinite Delivery Contract 36C26121D0050

The Department of Veterans Affairs Veterans Health Administration awarded an indefinite delivery contract to Cardinal Health 414, LLC for the provision of radiopharmaceuticals. The contract holds a potential value of $441,025.34 and a period of performance from February 2021 through September 2023. Three firm fixed price delivery orders have been awarded against this contract to date for the support of VA programs in Fresno, California. The delivery orders provide radiopharmaceutical products and services from Cardinal Health's location in Dublin, Ohio and within Fresno, with values of $385,849.84, $407,146.17, and $441,025.34 respectively. The contract aims to procure critical radiopharmaceuticals to support imaging procedures and care for veterans at VA medical centers in Fresno. As the largest healthcare services company in the U.S., Cardinal Health leverages extensive experience supporting VA efforts to provide quality care through nationwide facilities. The contract was awarded noncompetitively with no set-aside designation applied under the VA's Radioisotopes for Research and Diagnostics IDC vehicle.

The originating pre-solicitation notice indicated the VA Network Contracting Office planned to issue a request for quote seeking radiopharmaceuticals for the VA Central California Healthcare System in Fresno. The solicitation was subsequently issued on February 1, 2021 with responses due February 8, 2021, leading to the February 17, 2021 award to Cardinal Health. The contract and delivery orders executed through September 2023 aim to procure critical supplies ensuring veterans in the Fresno area receive needed radiopharmaceuticals and imaging services through the VA healthcare system.